Clinical Trial Update: New Generation IGRA in Immunocompromised Individuals

View source ↗

Summary

A completed trial evaluating a new generation interferon-gamma release assay (IGRA) for tuberculosis infection screening in immunocompromised individuals, inclu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tuberculosis

Snippet

Sponsor: Tuberculosis Network European Trialsgroup | Conditions: Monitoring, Immunologic, Active Tuberculosis | Status: COMPLETED